Read More Pharma Industry News Amgen and AstraZeneca’s Tezspire achieves key milestone in Phase 3 nasal polyps trial Amgen and AstraZeneca have revealed promising results from the Phase 3 Waypoint trial, demonstrating that Tezspire (tezepelumab-ekko) delivers… byPallavi MadhirajuMarch 3, 2025